EP1519705A1 - Preparations mousseuses - Google Patents

Preparations mousseuses

Info

Publication number
EP1519705A1
EP1519705A1 EP03740334A EP03740334A EP1519705A1 EP 1519705 A1 EP1519705 A1 EP 1519705A1 EP 03740334 A EP03740334 A EP 03740334A EP 03740334 A EP03740334 A EP 03740334A EP 1519705 A1 EP1519705 A1 EP 1519705A1
Authority
EP
European Patent Office
Prior art keywords
peg
group
carbon atoms
stearate
glyceryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP03740334A
Other languages
German (de)
English (en)
Inventor
Nadine Voigt
Thomas Raschke
Ilka Oelrichs
Alexander Filbry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of EP1519705A1 publication Critical patent/EP1519705A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to foamable cosmetic and dermatological preparations, in particular skin-care foamable cosmetic and dermatological preparations.
  • Foams or foam-like preparations belong to the disperse systems.
  • Emulsions are two- or multi-phase systems of two or more liquids which are insoluble or only slightly soluble in one another.
  • the liquids pure or as solutions
  • the liquids are present in an emulsion in a more or less fine distribution, which is generally only of limited stability.
  • Foams are structures made of gas-filled, spherical or polyhedral cells, which are delimited by liquid, semi-liquid, highly viscous or solid cell bridges.
  • the cell bridges connected via so-called nodes, form a coherent framework.
  • the foam lamellae (closed-cell foam) stretch between the cell bars. If the foam lamellae are destroyed or flow back into the cell webs at the end of foam formation, an open-cell foam is obtained.
  • Foams like emulsions, are also thermodynamically unstable, since surface energy can be obtained by reducing the surface area. The stability and therefore the existence of a foam depends on the extent to which it can prevent its self-destruction.
  • Cosmetic foams are generally dispersed systems composed of liquids and gases, the liquid being the dispersant and the gas being the dispersed substance. Foams made from low-viscosity liquids are temporarily stabilized by surface-active substances (surfactants, foam stabilizers). Because of their large inner surface, such surfactant foams have a strong adsorption capacity, which is used, for example, in cleaning and washing processes. Accordingly, cosmetic foams are used in particular in the areas of cleaning, for example as shaving cream, and hair care.
  • surfactants foam stabilizers
  • foaming agents surfactants or other surfactants that in addition to interfacial activity, they also have a certain ability to form films.
  • Cosmetic foams have the advantage over other cosmetic preparations that they allow a fine distribution of the product and in particular the active ingredients contained therein on the skin.
  • emulsion-based foams are often not very stable, which is why they usually collapse within about 24 hours.
  • a requirement of cosmetic preparations, however, is that they have a stability that is as long as possible.
  • Post-foaming preparations are often in special embodiments such as post-foaming shaving gels or the like.
  • Another disadvantage of the prior art is that unstable active ingredients, e.g. H. Active ingredients that are sensitive to oxidation (air) or light, for example, only in certain preparations that are difficult to formulate and in very few packaging materials - such as. B. aluminum tubes - can be presented. The skin feel of these products and the consumer acceptance of these packaging materials are often weak.
  • An object of the present invention was to enrich the prior art and to provide cosmetic or dermatological foamable preparations which do not have the disadvantages of the prior art.
  • foamable cosmetic or dermatological preparations containing A. at least one emulsifier selected from the group: polyglyceryl-3-methylglucose distearate and PEG ester and / or PEG ether with 30 to 100 Ethoxy units of the following structure (n between 30 and 100):
  • R1 and R2 are selected independently of one another from the group: hydrogen, alkyl and acyl radicals having 12 to 40 carbon atoms,
  • foamable is to be understood to mean that the preparations according to the invention form foams when they are foamed, ie when gas is blown into them, for example, or the preparations are (violently) beaten in the gas atmosphere in question, In the foams produced in this way, the gas bubbles can (arbitrarily) be distributed in one (or more) liquid phase (s), the foams not necessarily having the appearance of a foam macroscopically.
  • foamable cosmetic or dermatological preparations according to the invention can by foaming z.
  • the foam character can, for example, only become visible under a (light) microscope.
  • the foaming of the foamable preparations according to the invention - especially when the gas bubbles are too small to be recognized under a light microscope - can also be recognized from a large increase in volume of the system.
  • preparations according to the invention are extremely satisfactory preparations in every respect. It was particularly surprising that the foams produced from the foamable preparations according to the invention are extraordinarily stable, even with an unusually high gas volume. Accordingly, preparations in the sense of the present invention are particularly suitable to serve as the basis for product forms with a variety of uses.
  • the preparations according to the invention and the foams obtainable therefrom have very good sensory properties, such as, for example, the distributability on the skin or the ability to be absorbed into the skin, and are furthermore distinguished by an above-average skin care. Fine-bubble, rich foams of outstanding cosmetic elegance can be obtained from compositions according to the invention. Preparations which are particularly well tolerated by the skin can furthermore be obtained from compositions according to the invention, and valuable ingredients can be distributed particularly well on the skin.
  • the invention further relates to the use of foamable cosmetic or dermatological preparations containing A. at least one emulsifier selected from the group: polyglyceryl-3-methylglucose distearate and PEG ester and / or PEG ether with 30 to 100 ethoxy units of following structure (n between 30 and 100):
  • RMCHz-CHz-OJn-R 2 in which R1 and R2 are selected independently of one another from the group: hydrogen, alkyl and acyl radicals having 12 to 40 carbon atoms, B. at least one co-emulsifier, selected from the group: saturated and / or unsaturated, branched and / or unbranched fatty alcohols with a chain length of 10 to 28 carbon atoms, glyceryl stearate and
  • At least one foam-stabilizing surfactant selected from the group: N-acyl sarcosinates with a chain length of 10 to 28 carbon atoms, polyglycosides with a chain length of 10 to 28 carbon atoms and acyl glutamates with a chain length of 10 to 28 carbon atoms as cosmetic or dermatological basis for water-sensitive, hydrophilic active substances.
  • the emulsifier (s) are preferably selected from the following group: PEG-9 stearate, PEG-8 distearate, PEG-20 stearate, PEG-8 stearate, PEG-8 oleate, PEG-25 glyceryl trioleate, PEG-40 -Sorbitan lanolate, PEG-15-glyceryl ricinoleate, PEG-20-glyceryl stearate, PEG-20-glyceryl isostearate, PEG-20-glyceryl oleate, PEG-20-stearate, PEG-20-methylglucose sesquistearate, PEG-30-glyceryl isostearate, PEG-20 , PEG-30 stearate, PEG-30 glyceryl stearate, PEG-40 stearate, PEG-30 glyceryl laurate, PEG-50 stearate, PEG-100 stearate, PEG-150 laurate.
  • the co-emulsifier (s) are preferably selected from the following group: butyl octanol, butyl decanol, hexyl octanol, hexyl decanol, octyl dodecanol, behenyl alcohol (C 22 H 45 OH), cetearyl alcohol [a mixture of cetyl alcohol (C 1 ⁇ H 33 OH) and stearyl alcohol ( C ⁇ 8 H 37 OH)], lanolin alcohols (wool wax alcohols, which represent the unsaponifiable alcohol fraction of the wool wax, which is obtained after the saponification of wool wax). Cetyl and cetylstearyl alcohol are particularly preferred.
  • the total amount of emulators (one or more compounds) to be in the range from 0.001 to 20% by weight, advantageously from 0.002 to 15% by weight, in particular from 0.01 to 5 % By weight, based in each case on the total weight of the formulation.
  • the total amount of co-emulsifiers (one or more compounds) to be in the range from 0.001 to 20% by weight, advantageously from 0.002 to 15% by weight, in particular from 0.01 to 5% by weight. -%, each based on the total weight of the formulation.
  • the total amount of foam-stabilizing surfactants (one or more compounds) to be in the range from 0.0001 to 20% by weight, advantageously from 0.0005 to 10% by weight, in particular from 0.001 to 2% by weight, based in each case on the total weight of the formulation.
  • Aerosol containers according to the invention are spray devices with a filling of the liquid or pulp-like substances which are under the pressure of a propellant (compressed gas or aerosol packs).
  • propellant compressed gas or aerosol packs
  • Such containers can be equipped with valves of very different designs, which allow the contents to be removed as foam.
  • the pressure gas containers used are primarily cylindrical vessels made of metal (aluminum, tinplate, content ⁇ 1000 mL), protected or non-splintering glass or plastic (content ⁇ 220 mL) or splintering glass or plastic (content ⁇ 150 mL) in question, when choosing compressive strength and breaking strength, Corrosion resistance, easy fillability, possibly sterilization etc., but also aesthetic aspects, handiness, printability etc. play a role.
  • the maximum permissible operating pressure of spray cans made of metal at 50 ° C is 12 bar and the maximum filling volume at this temperature is approx. 90% of the total volume.
  • lower values for the operating pressure apply, depending on the container size and the propellant (whether liquefied, compressed or dissolved gas).
  • Cans made of tinplate, aluminum and glass are particularly advantageous for the purposes of the present invention.
  • metal cans can be painted inside (silver or gold painted), for which all commercially available interior protective paints are suitable.
  • Polyester, epoxyphenol and polyamideimide lacquers are preferred for the purposes of the present invention.
  • Foil laminations made of polyethylene (PE), polypropylene (PP) and / or polyethylene terephthalate (PET) inside the cans are also advantageous, especially for cans made of tinplate.
  • the compressed gas containers are usually one or two, but usually three-part cylindrical, conical or other shape. If plastics are used as spray container material, they should be resistant to chemicals and sterilization temperatures, gas-tight, impact-resistant and stable against internal pressures above 12 bar. In principle, polyacetals and polyamides are suitable for spray container purposes.
  • the internal structure of the spray cans and the valve construction are dependent on the intended use and the physical nature of the content - e.g. B. whether as a two- or three-phase system - very varied and can be determined by a person skilled in the art by simply trying out without inventive step.
  • suitable embodiments reference is made to the “Aerosol Technology Manual for Aersosol Packaging” (Wolfgang Tauscher, Melcher Verlag GmbH Heidelberg / Kunststoff, 1996).
  • Valves advantageous according to the invention can be designed with or without a riser pipe.
  • the individual parts from which valves according to the invention are usually constructed preferably consist of the following materials:
  • tinplate bright, gold or clear lacquered, foil-laminated (PE, PP or PET)
  • Aluminum bright, silver or gold lacquered, different lacquer variants, stoner mudge version
  • Sealing natural or synthetic elastomers or thermoplastic (sleeve gaskets, film-lined from PE or PP) inner and outer seals, e.g. B. from Perbunan, Buna, neoprene, butyl, CLB, LDPE, Viton, EPDM, chlorobutyl, bromobutyl and / or various compounds
  • Spring metal, particularly preferably V2A, stainless steel; Plastic and also elastomer
  • VPH holes VPH holes, RPT holes or slotted for overhead applications.
  • B polyacetal, PA, PE, POM and the like
  • Advantageous spray heads in the sense of the present invention are, for example, foam heads for upright use (holding the can vertically) or foam heads for overhead use with one or more channels.
  • the usual "classic" volatile, liquefied propellants such as dimethyl ether (DME) and / or linear or branched chain hydrocarbons with two to five carbon atoms (such as in particular ethane, propane, butane, isobutane and / or pentane) are suitable as blowing agents, which can be used alone or in a mixture with one another.
  • DME dimethyl ether
  • / or linear or branched chain hydrocarbons with two to five carbon atoms such as in particular ethane, propane, butane, isobutane and / or pentane
  • Compressed air and other pressurized gases such as air, oxygen, nitrogen, hydrogen, helium, krypton, xenon, radon, argon, laughing gas (N 2 O) and coal
  • nitrogen nitrogen
  • hydrogen hydrogen
  • helium helium
  • krypton xenon
  • radon radon
  • argon laughing gas
  • coal coal
  • CO 2 carbon dioxide
  • the gases mentioned can be used individually or in any mixtures with one another.
  • the volume fraction of propellant gas is advantageously selected from the range from 0.1 to 30% by volume, based on the total volume of filling material and propellant gas (corresponding to a volume fraction of 70 to 99.9% by volume filling material) ,
  • foams according to the invention are foamed using linear or branched-chain, halogenated or non-halogenated hydrocarbons.
  • Very particularly advantageous foams can be obtained by foaming the preparations according to the invention with carbon dioxide, oxygen, compressed air and / or nitrogen.
  • formulations according to the present invention may contain further emulsifiers.
  • the oil phase of the formulations according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, especially the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24 , in particular 12 to 18 carbon atoms.
  • the fatty acid triglycerides can for example be advantageously selected from the group of synthetic, semi-synthetic and natural oils, such as. B.
  • cocoglyceride olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, Palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil and the like.
  • z. B natural waxes of animal and vegetable origin, such as beeswax and other insect waxes, and berry wax, shea butter and / or lanolin (wool wax).
  • further advantageous polar oil components can also be selected from the group of esters from saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms and from the group of esters from aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 3 to 30 C atoms.
  • ester oils can then advantageously be selected from the group octyl palmitate, octyl co-coat, octyl isostearate, octyl dodeceyl myristate, octyl dodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-stonolate, n-stonolate, n-stonyl-n-stonate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearyl heptanoate, oleyl oleate, olerlerucate, erucyl oleate, erucylerucate
  • the oil phase can advantageously be selected from the group of dialkyl ethers and dialkyl carbonates.
  • oil component (s) from the group isoeikosan, neopentyl glycol diheptanoate, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, C ⁇ 2 . 13 alkyl lactate, di- 2 . 13- alkyl tartrate, triisostearin, dipentaerythrityl hexacaprylate / hexacaprate, propylene glycol monoisostearate, tri-caprylin, dimethyl isosorbide. It is particularly advantageous if the oil phase of the invented Formulations according to the invention have a content of C 12 -is alkyl benzoate or consist entirely of this.
  • Advantageous oil components are also z.
  • the oil phase can also advantageously also contain non-polar oils, for example those selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohexa- decane.
  • non-polar oils for example those selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes and isohexa- decane.
  • polyolefins polydecenes are the preferred substances.
  • the oil phase can advantageously also have a content of cyclic or linear silicone oils or consist entirely of such oils, although it is preferred to use an additional content of other oil phase components in addition to the silicone oil or the silicone oils.
  • Silicone oils are high-molecular synthetic polymeric compounds in which silicon atoms are linked in a chain and / or network-like manner via oxygen atoms and the remaining valences of silicon by hydrocarbon residues (mostly methyl, more rarely ethyl, propyl, phenyl) Groups, etc.) are saturated.
  • the silicone oils are systematically referred to as polyorganosiloxanes.
  • the methyl-substituted polyorganosiloxanes which are the most important compounds of this group in terms of quantity and are characterized by the following structural formula
  • Dimethicone is available in different chain lengths or with different molecular weights.
  • Particularly advantageous polyorganosiloxanes for the purposes of the present invention are, for example, dimethylpolysiloxanes [poly (dimethylsiloxane)], which are available, for example, from Th. Goldschmidt under the trade names Abil 10 to 10,000.
  • phenylmethylpolysiloxanes INCI: phenyl dimethicone, phenyl trimethicone
  • cyclic silicones octamethylcyclotetrasiloxane or decamethylcyclopentasiloxane
  • amino-modified silicones INCI: amodimethicone and silicone.
  • polysiloxane-polyalkylene copolymers (INCI: stearyl dimethicone and cetyl dimethicone) and dialkoxydimethyl polysiloxanes (stearoxy dimethicone and behenoxy stearyl dimethicone), which are available as different Abil-Wax types from Th. Goldschmidt.
  • other silicone oils can also be used advantageously for the purposes of the present invention, for example cetyldimethicone, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
  • the cosmetic and / or dermatological preparations according to the invention and foams obtainable therefrom can be composed as usual.
  • Preparations for skin care are particularly advantageous for the purposes of the present invention: they can be used for cosmetic and / or dermatological light protection, for treating the skin and / or hair and as a make-up product in decorative cosmetics.
  • Another advantageous embodiment of the present invention consists of after-sun products.
  • cosmetic or topical dermatological compositions can be used for the purposes of the present invention, for example as a skin protection cream, day or night cream, etc. It may be possible and advantageous to use the compositions according to the invention as the basis for pharmaceutical formulations.
  • the foams obtainable from preparations according to the invention can also represent “cleaning foams” which for example to remove make-up and / or make-up or as a mild wash foam - possibly also for impure skin.
  • cleaning foams can advantageously also be used as so-called “rinse off” preparations which are rinsed off the skin after use
  • Foams obtainable from cosmetic and / or dermatological preparations according to the invention can also advantageously be in the form of a foam for the care of the hair or the scalp, in particular a foam for inserting the hair, a foam which is used when the hair is blow-dried, a hairdressing and Treatment foam.
  • the cosmetic and dermatological preparations according to the invention and / or foams obtainable therefrom are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics.
  • the cosmetic and dermatological preparations according to the invention can contain cosmetic auxiliaries as are usually used in such preparations, e.g. B. preservatives, preservation aids, bactericides, perfumes, dyes, pigments that have a coloring effect, moisturizing and / or moisturizing substances, fillers that improve the feeling on the skin, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • cosmetic auxiliaries e.g. B. preservatives, preservation aids, bactericides, perfumes, dyes, pigments that have a coloring effect, moisturizing and / or moisturizing substances, fillers that improve the feeling on the skin, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
  • Advantageous preservatives for the purposes of the present invention are, for example, formaldehyde releasers (such as, for example, DMDM hydantoin), iodopropyl butyl carbamates (for example those available under the trade names Koncyl-L, Koncyl-S and Konkaben LMB from Lonza), parabens, Phenoxyethanol, ethanol, benzoic acid and the like.
  • the preservation system according to the invention advantageously also includes preservation aids, such as, for example, octoxyglycerol, glycine soya, etc.
  • antioxidants are used as additives or active ingredients.
  • the preparations contain gene advantageously one or more antioxidants. All of the antioxidants which are suitable or customary for cosmetic and / or dermatological applications can be used as inexpensive but nevertheless optional antioxidants.
  • the antioxidants are advantageously selected from the group consisting of amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-camosine, D-carnosine, L-camosine and their derivatives (e.g. anserine), carotenoids, carotenes (e.g. ⁇ -carotene, ß-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (e.g.
  • amino acids e.g. glycine, histidine, tyrosine, tryptophan
  • imidazoles e.g. urocanic acid
  • peptides such as D, L-camosine, D-carnosine, L-camosine and their derivatives (e.g. anserine)
  • carotenoids e.g
  • thioglucose e.g. thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl, and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters
  • salts dilaurylthiodipropionate, distearylthiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleotides and salts) and sulfoximine Compounds (e.g.
  • Buthioninsulfoximine, Homocysteinsulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptat hioninsulfoximine) in very low tolerable dosages e.g. B. pmol to ⁇ mol / kg
  • further (metal) chelators e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), ⁇ -hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, Bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g.
  • ⁇ -linolenic acid linoleic acid, oleic acid
  • folic acid and their derivatives ubiquinone and ubiquinol and their derivatives
  • vitamin C and derivatives e.g. B. ascorbyl palmitate, Mg - ascorbyl phosphate, ascorbyl acetate
  • tocopherols and derivatives e.g.
  • vitamin E acetate
  • vitamin A and derivatives vitamin A palmitate
  • water-soluble antioxidants such as vitamins, e.g. B. ascorbic acid and its derivatives.
  • vitamins e.g. B. ascorbic acid and its derivatives.
  • An astonishing property of the preparations according to the invention is that they are very good vehicles for cosmetic or dermatological active ingredients in the skin, preferred active ingredients being antioxidants which can protect the skin against oxidative stress. It was particularly surprising that the cosmetic or dermatological preparations according to the invention stabilize water-sensitive, hydrophilic active substances - in particular ascorbic acid - better against decay than the preparations of the prior art and that they are also excellent cosmetic and dermatological transport agents for ascorbic acid and / or ascorbyl compounds.
  • the amount of the antioxidants (one or more compounds) in the preparations is preferably 0.0001 to 30% by weight, particularly preferably 0.0005 to 10% by weight, in particular 0.001 to 5% by weight, based on the total weight the preparation.
  • antioxidants are vitamin E and its derivatives and vitamin A and its derivatives. If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation.
  • vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to add their respective concentrations in the range from 0.001 to 10% by weight, based on the total weight of the formulation choose.
  • the active ingredients can also be selected very advantageously from the group of lipophilic active ingredients, in particular from the following group:
  • the active substances from the group of refatting substances, for example purcellin oil, Eucerit and Neocerit.
  • the active ingredient (s) are particularly advantageously selected from the group of NO synthase inhibitors, in particular if the preparations according to the invention are intended for the treatment and prophylaxis of the symptoms of intrinsic and / or extrinsic skin aging and for the treatment and prophylaxis of the harmful effects of ultraviolet radiation on the skin ,
  • the preferred NO synthase inhibitor is nitroarginine.
  • the active ingredient (s) are also advantageously selected from the group comprising catechins and bile esters of catechins and aqueous or organic extracts from plants or parts of plants which contain catechins or bile esters of catechins, such as, for example, the leaves of Plant family Theaceae, especially the species Camellia sinensis (green tea).
  • catechins and bile esters of catechins and aqueous or organic extracts from plants or parts of plants which contain catechins or bile esters of catechins, such as, for example, the leaves of Plant family Theaceae, especially the species Camellia sinensis (green tea).
  • Their typical ingredients such as polyphenols or catechins, caffeine, vitamins, sugar, minerals, amino acids, lipids are particularly advantageous.
  • Catechins are a group of compounds which are to be understood as hydrogenated flavones or anthocyanidins and derivatives of "catechins” (catechol, 3,3 ', 4', 5,7-flavanpentaol, 2- (3,4- Dihydroxyphenyl) -chroman-3,5,7-triol) Also epicatechin ((2R, 3R) -3,3 ', 4', 5,7-flavanpentaol) is an advantageous active substance in the sense of the present invention.
  • Plant extracts containing catechins in particular extracts of green tea, such as.
  • Preferred active ingredients are also polyphenols or catechins from the group (-) - catechol, (+) - catechin, (-) - catechin gallate, (-) - gallocatechin gallate, (+) - epicatechin, (-) - epicatechin , (-) - epicatechin gallate, (-) - epigallocatechin, (-) - epigallocatechin gallate.
  • Flavon and its derivatives are advantageous active substances in the sense of the present invention. They are characterized by the following basic structure (substitution positions specified):
  • flavones usually occur in glycosidated form.
  • the flavonoids are preferably chosen from the group of substances of the generic structural formula
  • Zi to Z 7 are independently selected from the group H, OH, alkoxy and hydroxyalkoxy, where the alkoxy or hydroxyalkoxy groups can be branched and unbranched and can have 1 to 18 carbon atoms, and wherein Gly is selected from the Group of the mono- and oligoglycoside residues.
  • the flavonoids can also be advantageously selected from the group of substances of the generic structural formula
  • Z to Ze are independently selected from the group H, OH, alkoxy and hydroxyalkoxy, where the alkoxy or hydroxyalkoxy groups are branched and unbranched and can have 1 to 18 carbon atoms, and wherein Gly is selected from the group the mono- and oligoglycoside residues.
  • Such structures can preferably be selected from the group of substances of the generic structural formula
  • Gly Gly 2 and Gly 3 independently of one another represent monoglycoside residues or. Gly 2 or Gly 3 can also represent, individually or together, saturations by hydrogen atoms.
  • Gly, Gly 2 and Gly 3 are preferably selected independently of one another from the group of the hexosyl radicals, in particular the rhamnosyl radicals and glucosyl radicals.
  • hexosyl radicals for example allosyl, altrosyl, galactosyl, gulosyl, idosyl, mannosyl and talosyl, may also be used advantageously. It can also be advantageous according to the invention to use pentosyl residues.
  • Gly ⁇ Gly 2 and Gly 3 independently of one another represent monoglycoside residues or. Gly 2 or Gly 3 can also represent, individually or together, saturations by hydrogen atoms.
  • Glyi, Gly 2 and Gly 3 are preferably selected independently of one another from the group of the hexosyl radicals, in particular the rhamnosyl radicals and glucosyl radicals.
  • hexosyl radicals for example allosyl, altrosyl, galactosyl, gulosyl, idosyl, mannosyl and talosyl, may also be used advantageously. It can also be advantageous according to the invention to use pentosyl residues.
  • flavone glycosides from the group ⁇ -glucosyl rutin, ⁇ -glucosyl myrcetin, ⁇ -glucosyl iso-quercitrin, ⁇ -glucosyl iso-quercetin and ⁇ -glucosyl-quercitrin.
  • ⁇ -glucosylrutin is particularly preferred.
  • naringin aurantiin, naringenin-7-rhamnoglucosid
  • hesperidin 3 ', 5,7-trihydroxy-4'-methoxyflavanon-7-rutinoside
  • hesperidoside hesperetin-7-O-rutinoside
  • Rutin (3,3 ', 4', 5,7-pentahydroxyflyvon-3-rutinosid, quercetin-3-rutinosid, Sopho n, Birutan, Rutabion, taurutin, phytomelin, Melin), troxerutin (3,5-dihydroxy- 3,, 4 ', 7-tris (2-hydroxyethoxy) flavone-3- (6-0- (6-deoxy- ⁇ -L-mannopyranosyl) -beta-D-glucopy- ranosid)), monoxerutin (3, 3 ', 4', 5-tetrahydroxy-7- (2-hydroxyethoxy) flavon-3- (6-O- (6-deoxy- ⁇ -L-mannopyranosyl) -ß-D-glucopyranoside)), dihydrorobinetin (3,3 ', 4', 5 ', 7-pentahydroxyflavanone), taxifolin (3,3', 4 ', 5,7-pent
  • the active ingredient (s) from the group of ubiquinones and plastoquinones.
  • Coenzyme Q10 which is characterized by the following structural formula, is particularly advantageous:
  • Creatine and / or creatine derivatives are also preferred active substances for the purposes of the present invention. Creatine is characterized by the following structure:
  • Preferred derivatives are creatine phosphate and creatine sulfate, creatine acetate, creatine ascorbate and the derivatives esterified on the carboxyl group with mono- or polyfunctional alcohols.
  • acyl-camitines which are selected from the group of substances of the following general structural formula
  • R is selected from the group of branched and unbranched alkyl radicals having up to 10 carbon atoms
  • R is selected from the group of branched and unbranched alkyl radicals having up to 10 carbon atoms
  • Propionylcarnitine and in particular acetylcarnitine are preferred.
  • Both enantiomers (D- and L-form) can be used advantageously for the purposes of the present invention. the. It can also be advantageous to use any mixture of enantiomers, for example a racemate of D and L form.
  • the list of the active substances or combinations of active substances mentioned which can be used in the preparations according to the invention is of course not intended to be limiting.
  • the active ingredients can be used individually or in any combination with one another.
  • Skin aging is e.g. B. caused by endogenous, genetically determined factors. In the epidermis and dermis it occurs due to aging e.g. B. the following structural damage and malfunctions, which may also fall under the term "senile xerosis":
  • Exogenous factors such as UV light and chemical pollutants
  • exogenous factors e.g. B. the following structural damage and functional disorders in the skin, which go beyond the extent and quality of the damage with chronological aging:
  • formulations according to the invention can also have an anti-wrinkle effect or considerably increase the effect of known anti-wrinkle active ingredients. Accordingly, formulations within the meaning of the present invention are particularly advantageous for the prophylaxis and treatment of cosmetic or dermatological tological skin changes, such as z. B. occur during skin aging. They are also advantageous against the appearance of dry or rough skin.
  • the present invention therefore relates to products for the care of the naturally aged skin and for the treatment of the consequential damage caused by photoaging, in particular the phenomena listed under a) to g).
  • the water phase of the preparations according to the invention can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those having a low C number, preferably ethanol and / or isopropanol, diols or polyols having a low C number, and their ethers, preferably propylene glycol, glycerol, ethylene glycol, Ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analog products, polymers, foam stabilizers, electrolytes and moisturizers.
  • customary cosmetic auxiliaries such as, for example, alcohols, in particular those having a low C number, preferably ethanol and / or isopropanol, diols or polyols having a low C number, and their ethers, preferably propylene glycol, glycerol, ethylene glycol,
  • Moisturizers are substances or mixtures of substances that give cosmetic or dermatological preparations the property of reducing the release of moisture from the horny layer (also known as trans-epidermal water loss (TEWL)) and / or hydrating the skin after application or distribution on the skin surface To influence the horny layer positively.
  • TEWL trans-epidermal water loss
  • moisturizers for the purposes of the present invention are, for example, glycerol, lactic acid, pyrrolidone carboxylic acid and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gelable polysaccharides. Particularly advantageous are, for example, hyaluronic acid, chitosan and / or a fucose-rich polysaccharide, which is filed in the Chemical Abstracts under the registration number 178463-23-5 and z. B. under the name Fucogel®1000 from the company SOLABIA S.A. is available.
  • the cosmetic and dermatological preparations according to the invention can contain dyes and / or color pigments, in particular if they are in the form of decorative cosmetics.
  • the dyes and pigments can be found in the corresponding positive list of the Cosmetics Regulation or the EC list of cosmetic colorants to be selected. In most cases, they are identical to the colorants approved for food.
  • Advantageous color pigments are, for example, titanium dioxide, mica, iron oxides (eg Fe 2 0 3 , Fe 3 0 4 , FeO (OH)) and / or tin oxide.
  • Advantageous dyes are, for example, carmine, Berlin blue, chrome oxide green, ultramarine blue and / or manganese violet. It is particularly advantageous to choose the dyes and / or color pigments from the Rowe Color Index, 3rd edition, Society of Dyers and Colorists, Bradford, England, 1971.
  • the formulations according to the invention are in the form of products which are used on the face, it is advantageous to choose one or more substances from the following group as the dye: 2,4-dihydroxyazobenzene, 1- (2'-chloro-4'- nitro-1'-phenylazo) -2-hydroxynaphthalene, ceres red, 2- (sulfo-1-naphthylazo) -1-naphthol-4-sulfonic acid, calcium salt of 2-hydroxy-1, 2'-azonaphthalene-1'- sulfonic acid, calcium and barium salts of 1- (2-sulfo-4-methyl-1-phenylazo) -2-naphthylcarboxylic acid, calcium salt of 1- (2-sulfo-1-naphthylazo) -2-hydroxynaphthalene-3-carboxylic acid, aluminum salt 1- (4-sulfo-1-phenylazo) -2-naphthol-6-sulfonic acid, aluminum
  • oil-soluble natural dyes such as. B. paprika extracts, ß-carotene or cochineal.
  • Formulations containing pearlescent pigments are also advantageous for the purposes of the present invention.
  • the types of pearlescent pigments listed below are particularly preferred: 1. Natural pearlescent pigments, such as. B.
  • Layer-substrate pigments e.g. B. mica / metal oxide
  • Pearlescent pigments are based, for example, on powdered pigments or castor oil dispersions of bismuth oxychloride and / or titanium dioxide and bismuth oxychloride and / or titanium dioxide on mica. Particularly advantageous is e.g. B. the gloss pigment listed under CIN 77163.
  • pearlescent pigment types based on mica / metal oxide are also advantageous:
  • B the pearlescent pigments available from Merck under the trade names Timiron, Colorona or Dichrona.
  • pearlescent pigments which are advantageous in the sense of the present invention are obtainable in numerous ways known per se.
  • other substrates besides mica can be coated with other metal oxides, such as. B. silica and the like.
  • metal oxides such as. B. silica and the like.
  • Ti0 2 and Fe 2 0 3 coated Si0 2 particles are advantageous for. B. with Ti0 2 and Fe 2 0 3 coated Si0 2 particles ("Ronasphe- ren "), which are sold by Merck and are particularly suitable for the optical reduction of fine wrinkles.
  • Iron pearlescent pigments which are produced without the use of mica are particularly preferred. Such pigments are e.g. B. available under the trade name Sicopearl copper 1000 from BASF.
  • effect pigments which are available from Flora Tech under the trade name Metasomes Standard / Glitter in various colors (yello, red, green, blue).
  • the glitter particles are present in mixtures with various auxiliaries and dyes (such as, for example, the dyes with the Color Index (Cl) numbers 19140, 77007, 77289, 77491).
  • the dyes and pigments can be present both individually and in a mixture and can be mutually coated, different color effects generally being produced by different coating thicknesses.
  • the total amount of dyes and coloring pigments is advantageously from the range of z. B. 0.1% by weight to 30% by weight, preferably from 0.5 to 15% by weight, in particular from 1.0 to 10% by weight, in each case based on the total weight of the preparations ,
  • UV-A or UV-B filter substances are usually incorporated into day creams or makeup products.
  • UV protection substances like antioxidants and, if desired, preservatives, also provide effective protection of the preparations themselves against spoilage.
  • Cosmetic and dermatological preparations which are in the form of a sunscreen are also favorable.
  • the preparations preferably contain, in addition to one or more UV filter substances according to the invention, at least one further UV-A and / or UV-B filter substance.
  • the wording may, although not necessary, optionally also contain one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or oil phase.
  • the preparations according to the present invention can furthermore advantageously also be in the form of so-called oil-free cosmetic or dermatological emulsions which contain a water phase and at least one UV filter substance which is liquid at room temperature as a further phase and which, in particular, can advantageously also be free of further oil components.
  • Preferred inorganic pigments are metal oxides and / or other metal compounds which are sparingly soluble or insoluble in water, in particular oxides of titanium (Ti0 2 ), zinc (ZnO), iron (e.g. Fe 2 0 3 ), zirconium (Zr0 2 ), silicon ( Si0 2 ), manganese (e.g. MnO), aluminum (Al 2 0 3 ), cerium (e.g. Ce 2 0 3 ), mixed oxides of the corresponding metals as well as mixtures of such oxides and the sulfate of barium (BaSO 4 ).
  • the pigments can also advantageously be used in the form of commercially available oily or aqueous predispersions. Dispersing aids and / or solubilizing agents can advantageously be added to these predispersions.
  • the pigments can advantageously be surface-treated (“coated”), for example a hydrophilic, amphiphilic or hydrophobic character should be formed or retained.
  • This surface treatment can best hen that the pigments are provided with a thin hydrophilic and / or hydrophobic inorganic and / or organic layer by methods known per se.
  • the various surface coatings can also contain water.
  • Inorganic surface coatings in the sense of the present invention can consist of aluminum oxide (Al 2 0 3 ), aluminum hydroxide Al (OH) 3 , or aluminum oxide hydrate (also: alumina, CAS no .: 1333-84-2), sodium hexametaphosphate (NaP0 3 ) ⁇ , sodium metaphosphate (NaP0 3 ) n , silicon dioxide (Si0 2 ) (also: silica, CAS No .: 7631-86-9), or iron oxide (Fe 2 0 3 ).
  • Al 2 0 3 aluminum oxide
  • Al (OH) 3 aluminum hydroxide Al
  • aluminum oxide hydrate also: alumina, CAS no .: 1333-84-2
  • sodium hexametaphosphate NaP0 3
  • sodium metaphosphate NaP0 3
  • silicon dioxide Si0 2
  • Si0 2 also: silica, CAS No .: 7631-86-9
  • iron oxide Fe 2 0 3
  • Organic surface coatings in the sense of the present invention can consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxane (methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane Units and silica gel) or alginic acid.
  • dimethylpolysiloxane also: dimethicone
  • methicone methylpolysiloxane
  • simethicone a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 dimethylsiloxane Units and silica gel
  • alginic acid can consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxan
  • Zinc oxide particles and predispersions of zinc oxide particles suitable according to the invention are available under the following trade names from the companies listed:
  • Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available under the following trade names from the companies listed:
  • Latex particles which are advantageous according to the invention are those described in the following documents: US Pat. No. 5,663,213 and EP 0 761 201. Particularly advantageous latex particles are those which are formed from water and styrene / acrylate copolymers and, for. B. are available under the trade name "Alliance SunSphere” from Rohm & Haas.
  • UV-A filter substances for the purposes of the present invention are dibenzoyl methane dehvate, in particular 4- (tert-butyl) -4'-methoxydibenzoyl methane (CAS No. 70356-09-1), which is available from Givaudan under the Parsol brand ® 1789 and is sold by Merck under the trade name Eusolex® 9020.
  • UV filter substances in the sense of the present invention are sulfonated, water-soluble UV filters, such as.
  • UV filter substances for the purposes of the present invention are also benzoxazole derivatives, which are distinguished by the following structural formula,
  • R 1 , R 2 and R 3 are independently selected from the group of branched or unbranched, saturated or unsaturated alkyl radicals having 1 to 10 carbon atoms. It is particularly advantageous according to the invention to choose the radicals R 1 and R 2 the same, in particular from the group of the branched alkyl radicals having 3 to 5 carbon atoms. It is furthermore particularly advantageous for the purposes of the present invention if R 3 is an unbranched or branched alkyl radical having 8 carbon atoms, in particular the 2-ethylhexyl radical.
  • Benzoxazole derivative which is particularly preferred according to the invention is 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1, 3,5-triazine with CAS No. 288254-16-0, which is characterized by the structural formula
  • the benzoxazole derivative (s) are advantageously present in dissolved form in the cosmetic preparations according to the invention. However, it may also be advantageous if the benzoxazole derivative or derivatives in pigmentary, ie. H. undissolved form - for example in particle sizes from 10 nm to 300 nm.
  • UV filter substances in the sense of the present invention are also so-called hydroxybenzophenones.
  • Hydroxybenzophenones are characterized by the following structural formula:
  • R 1 and R 2 are independently hydrogen, dC d-alkyl, C 3 -C 10 cycloalkyl or C 3 -C ⁇ 0 cycloalkenyl, the substituents R 1 and R 2 together with the nitrogen atom to which they are attached , can form a 5- or 6-ring and
  • R 3 represents a CrC ⁇ alkyl radical.
  • a particularly advantageous hydroxybenzophenone for the purposes of the present invention is 2- (4'-diethylamino-2'-hydoxybenzoyl) benzoic acid hexyl ester (also: aminobenzophenone), which is distinguished by the following structure:
  • Advantageous UV filter substances in the sense of the present invention are also so-called broadband filters, i.e. Filter substances that absorb both UV-A and UV-B radiation.
  • Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as. B.
  • Triazone which is sold by BASF Aktiengesellschaft under the trade name UVINUL® T 150;
  • An advantageous broadband filter in the sense of the present invention is also the 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol ) (INCI: Methylene Bis-Benztriazolyl Tetramethylbutylphenol), which is available, for example, under the trade name Tinosorb® M from CIBA-Chemicals GmbH.
  • Another advantageous broadband filter for the purposes of the present invention is 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3-tetramethyl-1- [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol (CAS No .: 155633-54-8) with the INCI name Drometrizole Trisiloxane.
  • the other UV filter substances can be oil-soluble or water-soluble.
  • Advantageous oil-soluble filter substances are e.g. B .:
  • 3-benzylidene camphor derivatives preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor;
  • 4-aminobenzoic acid derivatives preferably 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester, 4- (dimethylamino) benzoic acid amyl ester;
  • esters of benzalmalonic acid preferably 4-methoxybenzalmalonic acid di (2-ethylhexyl) ester
  • esters of cinnamic acid preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone and
  • Advantageous water-soluble filter substances are e.g. B .:
  • Sulfonic acid derivatives of 3-benzylidene camphor such as. B. 4- (2-oxo-3-bomylidene methyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidene methyl) sulfonic acid and salts thereof.
  • a further light protection filter substance according to the invention to be used advantageously is ethylhexyl-2-cyano-3,3-diphenyl acrylate, sold under the name Uvinul ® N 539 T is available (octocrylene) from BASF.
  • Particularly advantageous preparations in the sense of the present invention which are distinguished by a high or very high UV-A protection, preferably contain, in addition to the filter substance (s) according to the invention, further UV-A and / or broadband filters, in particular dibenzoylmethane dehvate [ for example the 4- (tert-butyl) -4'-methoxydibenzoylmethane] and / or the 2,4-bis - ⁇ [4- (2-ethylhexyloxy) -2-hydroxy] phenyl ⁇ -6- (4-methoxyphenyl) -1, 3,5-triazine and / or phenylene-1,4, bis (2-benzimidazyl) -3,3'-5,5'-tetrasuifonic acid bis-sodium salt in each case individually or in any Combinations with each other.
  • dibenzoylmethane dehvate for example the 4- (tert-butyl) -4'-methoxydibenzo
  • the preparations according to the present invention advantageously contain the substances which absorb UV radiation in the UV-A and / or UV-B range in a total amount of, for. B. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 20 wt .-%, in particular 1, 0 to 15.0 wt .-%, each based on the total weight of the preparations to cosmetic To provide preparations that protect the hair or skin from the entire range of ultraviolet radiation.
  • the preparations according to the present invention can furthermore advantageously also contain self-tanning substances, such as, for example, dihydroxyacteon and / or melanin derivatives in concentrations of 0.1% by weight to 5% by weight, in particular 0.5 to 3% by weight, in each case based on the total weight of the preparation.
  • self-tanning substances such as, for example, dihydroxyacteon and / or melanin derivatives in concentrations of 0.1% by weight to 5% by weight, in particular 0.5 to 3% by weight, in each case based on the total weight of the preparation.
  • Example 1 (foam-shaped O / W cream):
  • the foaming can e.g. B. done by blowing gas into the preparations or beating, shaking, spraying or stirring in the relevant gas atmosphere (violently).
  • the foaming can e.g. B. done by blowing gas into the preparations or beating, shaking, spraying or stirring in the relevant gas atmosphere (violently).
  • the foaming can e.g. B. done by blowing gas into the preparations or beating, shaking, spraying or stirring in the relevant gas atmosphere (violently).
  • Example 5 foam-shaped O / W sun protection cream:
  • the foaming can e.g. B. done by blowing gas into the preparations or beating, shaking, spraying or stirring in the relevant gas atmosphere (violently).
  • the foaming can e.g. B. done by blowing gas into the preparations or beating, shaking, spraying or stirring in the relevant gas atmosphere (violently).
  • the foaming can e.g. B. done by blowing gas into the preparations or beating, shaking, spraying or stirring in the relevant gas atmosphere (violently).
  • Example 9 (foam-shaped O / W cream):
  • the foaming can e.g. B. done by blowing gas into the preparations or beating, shaking, spraying or stirring in the relevant gas atmosphere (violently).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des préparations cosmétiques ou dermatologiques mousseuses contenant : A. au moins un émulsifiant sélectionné dans le groupe composé de distéarate de polyglycéryle-3-méthyle-glucose et d'ester PEG et/ou éther PEG ayant 30 à 100 unités d'éthoxy de la structure suivante (n étant compris entre 30 et 100): R1-(CH2-CH2-0)n-R2, où R1 et R2 sont sélectionnés indépendamment l'un de l'autre dans le groupe composé d'hydrogène, groupes d'alkyle et d'acyle ayant 12 à 40 atomes de carbone ; B. au moins un co-émulsifiant sélectionné dans le groupe composé d'alcools gras saturés et/ou non saturés, ramifiés et/ou non ramifiés ayant une longueur de chaîne de 10 à 28 atomes de carbone, stéarate de glycéryle et C. au moins un tensio-actif stabilisateur de mousse sélectionné dans le groupe composé de N-Acylsarcosinate ayant une longueur de chaîne de 10 à 28 atomes de carbone, de polyglycoside ayant une longueur de chaîne de 10 à 28 atomes de carbone et de glutamate d'acyle ayant une longueur de chaîne de 10 à 28 atomes de carbone. L'invention concerne également leur utilisation pour des principes actifs hydrophiles sensibles à l'eau et leur procédé de production.
EP03740334A 2002-06-25 2003-06-25 Preparations mousseuses Ceased EP1519705A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2002128229 DE10228229A1 (de) 2002-06-25 2002-06-25 Schäumbare Zubereitungen
DE10228229 2002-06-25
PCT/EP2003/006684 WO2004000243A1 (fr) 2002-06-25 2003-06-25 Preparations mousseuses

Publications (1)

Publication Number Publication Date
EP1519705A1 true EP1519705A1 (fr) 2005-04-06

Family

ID=29795867

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03740334A Ceased EP1519705A1 (fr) 2002-06-25 2003-06-25 Preparations mousseuses

Country Status (3)

Country Link
EP (1) EP1519705A1 (fr)
DE (1) DE10228229A1 (fr)
WO (1) WO2004000243A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005004187A1 (de) * 2005-01-29 2006-08-10 Beiersdorf Ag Kosmetische Zubereitung enthaltend oxidationsempfindliche Wirkstoffe
DE202010011395U1 (de) 2010-08-13 2010-11-11 Beiersdorf Ag Stabilisierte W/O-Emulsionen
DE102010034389B4 (de) 2010-08-13 2018-03-22 Beiersdorf Ag Stabilisierte W/O-Emulsionen
DE102010050774A1 (de) * 2010-11-10 2012-05-10 Beiersdorf Ag Kosmetisches Sonnenschutzspray
DE102011018924A1 (de) 2011-04-28 2012-10-31 Tunap Industrie Chemie Gmbh & Co. Produktions Kg OW-Emulsionskonzentrat, Verfahren zu dessen Herstellung und dieses enthaltendes Hautkosmetikum
FR3066914B1 (fr) * 2017-06-02 2019-07-12 Laboratoires M&L Composition cosmetique foisonnee a haute teneur en beurre vegetal

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1423179A (en) * 1973-05-16 1976-01-28 Wilkinson Sword Ltd Pressurised shaving foam dispensers
US4609544A (en) * 1983-07-05 1986-09-02 Repligen Corporation Process for tanning the skin
US4515773A (en) * 1983-07-05 1985-05-07 Repligen Corporation Skin tanning composition and method
DE3628531A1 (de) * 1986-08-22 1988-02-25 Merz & Co Gmbh & Co Verschaeumbare cremes
DE4230076C2 (de) * 1992-09-09 1995-12-14 Beiersdorf Ag cis-Urocaninsäure als Antioxidans
FR2745716B1 (fr) * 1996-03-07 1998-04-17 Oreal Emulsions huile-dans-eau moussantes pressurisables ultrafines
AU9162498A (en) * 1997-08-18 1999-03-08 Neubourg, Stephanie Foaming skin cream, uses thereof and a method for producing the same
DE19858241A1 (de) * 1998-12-17 2000-06-21 Henkel Kgaa Verdickte Zubereitung wasserlöslicher Tenside
DE10016875A1 (de) * 2000-04-05 2001-10-18 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen, enthaltend erhöhte Elektrolytkonzentrationen
DE10035513A1 (de) * 2000-07-21 2002-01-31 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Cyclodextrinen und mindestens einem Chinon und/oder mindestens einem Hydrochinon und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
DE10039063A1 (de) * 2000-08-10 2002-02-21 Beiersdorf Ag Kosmetische und dermatologische Zubereitung mit einem Gehalt an Cyclodextrinen zur Beseitigung von Sebum
DE10063342A1 (de) * 2000-12-19 2002-06-20 Beiersdorf Ag Selbstschäumende oder schaumförmige Zubereitungen
DE10063340A1 (de) * 2000-12-19 2002-08-29 Beiersdorf Ag Selbstschäumende oder schaumförmige Zubereitungen
DE10063341A1 (de) * 2000-12-19 2002-06-20 Beiersdorf Ag Selbstschäumende oder schaumförmige Zubereitungen
DE10063658A1 (de) * 2000-12-20 2002-07-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen in Form von W/O/W-Emulsionen mit einem Gehalt an Sterinen und /oder C12-C-40-Fettsäure
DE10063659A1 (de) * 2000-12-20 2002-07-04 Beiersdorf Ag Verfahren zur Herstellung von versprühbaren O/W-Emulsionen
DE10063660A1 (de) * 2000-12-20 2002-07-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen mit einem Gehalt an Sterinen und/oder C¶1¶¶2¶-C¶4¶¶0¶-Fettsäuren

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004000243A1 *

Also Published As

Publication number Publication date
DE10228229A1 (de) 2004-03-18
WO2004000243A1 (fr) 2003-12-31

Similar Documents

Publication Publication Date Title
EP1411884A2 (fr) Preparations moussantes
DE10063342A1 (de) Selbstschäumende oder schaumförmige Zubereitungen
DE10162844A1 (de) Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Bis-Resorcinyltriazinderivaten und Benzoxazol-Derivaten
EP1557160B1 (fr) émulsions huile-dans-eau moussantes
DE10154627A1 (de) Kosmetische oder dermatologische getränkte Tücher
EP1458345A1 (fr) Formulations cosmetiques et dermatologiques a effet de protection solaire, contenant des substances filtrant les u.v., solubles dans l'eau et des derives de benzoxazole
DE10162842A1 (de) Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Benzotriazolen und Benzoxazol-Derivaten
EP1372577A1 (fr) Preparations moussantes ou mousseuses comprenant des substances solides particulaires hydrophobes et/ou rendues hydrophobes et/ou d'absorption d'huile
WO2006094551A1 (fr) Utilisation de preparations cosmetiques presentant une teneur en oxygene libre sans liaison moleculaire
DE10063341A1 (de) Selbstschäumende oder schaumförmige Zubereitungen
EP1474099A1 (fr) Emulsions e/h fluides pulverisables
DE10063340A1 (de) Selbstschäumende oder schaumförmige Zubereitungen
EP1277455B1 (fr) Compositions moussantes
DE10134729A1 (de) Schäumbare Zubereitungen
EP1519705A1 (fr) Preparations mousseuses
DE10206798A1 (de) Zweiphasige Sonnenschutzzubereitungen mit O/W-Emulsion
WO2003070202A1 (fr) Preparations de protection solaire a deux phases contenant une emulsion de type huileux
DE10214054A1 (de) Wasserfeste kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Alpha Olefin/Maleinsäureanhydrid-Copolymeren
EP1370216A2 (fr) Preparations auto-moussantes ou de type mousse contenant des gelifiants inorganiques
DE10214058A1 (de) Wasserfeste kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Polyoxyethylen-Polydodecylglykol-Blockpolymeren
DE10206795A1 (de) Zweiphasige kosmetische oder dermatologische Zubereitungen mit einer Mikroemulsion
DE10249367A1 (de) Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Hydroxybenzophenonen und Benzoxazol-Derivaten

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RASCHKE, THOMAS

Inventor name: VOIGT, NADINE

Inventor name: FILBRY, ALEXANDER

Inventor name: OELRICHS, ILKA

17Q First examination report despatched

Effective date: 20051223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20070818